NO160001C - Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater. - Google Patents

Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.

Info

Publication number
NO160001C
NO160001C NO834437A NO834437A NO160001C NO 160001 C NO160001 C NO 160001C NO 834437 A NO834437 A NO 834437A NO 834437 A NO834437 A NO 834437A NO 160001 C NO160001 C NO 160001C
Authority
NO
Norway
Prior art keywords
azolon
hetero
derivatives
preparation
therapeutic active
Prior art date
Application number
NO834437A
Other languages
English (en)
Other versions
NO160001B (no
NO834437L (no
Inventor
Christopher Andrew Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO834437L publication Critical patent/NO834437L/no
Publication of NO160001B publication Critical patent/NO160001B/no
Publication of NO160001C publication Critical patent/NO160001C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO834437A 1982-12-06 1983-12-02 Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater. NO160001C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US44733782A 1982-12-06 1982-12-06
US06/545,450 US4556670A (en) 1982-12-06 1983-10-28 Spiro-3-hetero-azolones for treatment of diabetic complications

Publications (3)

Publication Number Publication Date
NO834437L NO834437L (no) 1984-06-07
NO160001B NO160001B (no) 1988-11-21
NO160001C true NO160001C (no) 1989-03-01

Family

ID=27034944

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834437A NO160001C (no) 1982-12-06 1983-12-02 Analogifremgangsm te for fremstilling av terapeutisk aktive spiro-3-hetero-azolon-derivater.

Country Status (21)

Country Link
US (1) US4556670A (no)
EP (1) EP0115133B1 (no)
KR (1) KR860001581B1 (no)
AU (1) AU545409B2 (no)
BG (1) BG44708A3 (no)
CA (1) CA1204763A (no)
DD (1) DD219482A5 (no)
DE (1) DE3379043D1 (no)
DK (1) DK558283A (no)
ES (1) ES527780A0 (no)
FI (1) FI80267C (no)
GR (1) GR78787B (no)
IE (1) IE56345B1 (no)
IL (1) IL70379A (no)
NO (1) NO160001C (no)
NZ (1) NZ206484A (no)
PH (1) PH19622A (no)
PL (1) PL142143B1 (no)
PT (1) PT77760B (no)
RO (1) RO88202B (no)
YU (1) YU43557B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0159143B1 (en) * 1984-03-23 1987-12-16 Pfizer Inc. Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4575507A (en) 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
GB2355264A (en) 1999-09-30 2001-04-18 Merck & Co Inc Spirohydantoin derivatives useful as alpha 1a adrenoceptor antagonists
WO2003088915A2 (en) * 2002-04-18 2003-10-30 University Of Virginia Patent Foundation Novel sodium channel blockers
EP1569915A4 (en) * 2002-12-04 2007-07-11 Merck & Co Inc SPIROCYCLIC UREAS, COMPOSITIONS CONTAINING SAME, AND METHODS OF USE
JO3501B1 (ar) * 2014-12-22 2020-07-05 Servier Lab مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2872454A (en) * 1959-02-03 Spiro-hydantoins from x-chloro-
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3985888A (en) * 1969-07-24 1976-10-12 Richardson-Merrell Inc. Methods of inducing sedation using certain spiroalkanone-imides
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4200642A (en) * 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
US4181729A (en) * 1979-03-21 1980-01-01 Pfizer Inc. Phenyl or phenoxy substituted spiro-imidazolidinedione derivatives
US4226875A (en) * 1979-04-02 1980-10-07 Pfizer Inc. Novel spiro-oxazolidinediones
US4307108A (en) * 1979-12-26 1981-12-22 Pfizer Inc. Method for lowering sorbitol levels using spiro-imides
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation

Also Published As

Publication number Publication date
PL142143B1 (en) 1987-09-30
US4556670A (en) 1985-12-03
YU237183A (en) 1986-02-28
PT77760B (en) 1986-05-30
AU2196883A (en) 1984-06-14
PH19622A (en) 1986-05-30
EP0115133A1 (en) 1984-08-08
FI834457A (fi) 1984-06-07
DK558283D0 (da) 1983-12-05
FI80267C (fi) 1990-05-10
IL70379A (en) 1988-10-31
NO160001B (no) 1988-11-21
RO88202B (ro) 1985-12-31
DK558283A (da) 1984-07-11
RO88202A (ro) 1985-12-30
KR860001581B1 (ko) 1986-10-10
NZ206484A (en) 1987-07-31
FI834457A0 (fi) 1983-12-05
GR78787B (no) 1984-10-02
PL244966A1 (en) 1985-05-21
BG44708A3 (bg) 1989-01-16
ES8601912A1 (es) 1985-11-16
DE3379043D1 (en) 1989-03-02
YU43557B (en) 1989-08-31
IL70379A0 (en) 1984-03-30
AU545409B2 (en) 1985-07-11
NO834437L (no) 1984-06-07
DD219482A5 (de) 1985-03-06
PT77760A (en) 1983-12-01
CA1204763A (en) 1986-05-20
ES527780A0 (es) 1985-11-16
IE56345B1 (en) 1991-07-03
EP0115133B1 (en) 1989-01-25
IE832854L (en) 1984-06-06
KR840006975A (ko) 1984-12-04
FI80267B (fi) 1990-01-31

Similar Documents

Publication Publication Date Title
NO158099C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO156864B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive piperinderivater.
NO164835C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyril-derivater.
NO162764C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinderivater.
NO165239C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-benzyl-aminoalkyl-pyrrolidinon-derivater.
NO165192C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive glyserolderivater.
NO152129C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive omega-cyan-1, omega-difenyl-azaalkanderivater
NO814136L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 8-arylalkyl-3-fenyl-3-notropanol-derivater
NO156787C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO158183C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylfenylamidiner.
NO159654C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 2-guanidin-4-heteroaryltiazolderivater.
NO161676C (no) Analogifremgangsm te til fremstilling av terapeutisk aktive mitosanderivater.
NO161562C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive ergolinderivater.
NO162155C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylkarbonoksylsyrederivater.
NO158941C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 4-piperidino-kinazolinderivater.
NO161559C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive triazolderivater.
NO164897C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxazolidinonderivater.
NO160079C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive cefem-derivater.
NO161738C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive imidazolinderivater.
NO158739C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-piperazinopyrimidinderivater.
NO160511C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenyl-cyklo-butanderivater.
NO160000C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive forbindelser.
NO168478C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive vinylthioacetamido-oxacefalosporinderivater.
NO160512C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karbostyrilderivater.
NO813821L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indolinon-derivater